We like low beta stocks, and ResMed is one of them.
Solid balance sheet and high profit margin.
Not cheap based on P/E, but justified by high RoE and high margins.
Solid balance sheet and high profit margin.
Not cheap based on P/E, but justified by high RoE and high margins.